» Articles » PMID: 35492376

Tie Decay and Dissolution: Contentious Prescribing Practices in the Prescription Drug Epidemic

Overview
Date 2022 May 2
PMID 35492376
Authors
Affiliations
Soon will be listed here.
Abstract

Although a substantial body of work has investigated drivers of tie formation, there is growing interest in understanding why relationships decay or dissolve altogether. The networks literature has tended to conceptualize tie decay as driven by processes similar to those underlying tie formation. Yet information that is revealed through ongoing interactions can exert different effects on tie formation and tie decay. This paper investigates how tie decay and tie formation processes differ by focusing on contentious practices. To the extent that information about dissimilarities in contentious practices is learned through ongoing interactions, it can exert diverging effects on tie formation and tie decay. Using a longitudinal data set of 141,543 physician dyads, we find that differences in contentious prescribing led ties to weaken or dissolve altogether but did not affect tie formation. The more contentious the practice and the more information available about the practice, the stronger the effect on tie decay and dissolution. Collectively, these findings contribute to a more nuanced understanding of relationship evolution as an unfolding process through which deeper-level differences are revealed and shape the outcome of the tie.

References
1.
Fenton M, Keyes K, Martins S, Hasin D . The role of a prescription in anxiety medication use, abuse, and dependence. Am J Psychiatry. 2010; 167(10):1247-53. PMC: 3756550. DOI: 10.1176/appi.ajp.2010.09081132. View

2.
Paulozzi L, Mack K, Hockenberry J . Vital signs: variation among States in prescribing of opioid pain relievers and benzodiazepines - United States, 2012. MMWR Morb Mortal Wkly Rep. 2014; 63(26):563-8. PMC: 4584903. View

3.
Ross-Degnan D, Simoni-Wastila L, Brown J, Gao X, Mah C, Cosler L . A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a Medicaid population. Int J Psychiatry Med. 2004; 34(2):103-23. DOI: 10.2190/8FR4-QYY1-7MYG-2AGJ. View

4.
Ong M, Olson K, Chadwick L, Liu C, Mandl K . The Impact of Provider Networks on the Co-Prescriptions of Interacting Drugs: A Claims-Based Analysis. Drug Saf. 2016; 40(3):263-272. PMC: 5385257. DOI: 10.1007/s40264-016-0490-1. View

5.
Kossinets G, Watts D . Empirical analysis of an evolving social network. Science. 2006; 311(5757):88-90. DOI: 10.1126/science.1116869. View